Legislative and regulatory instruments are in place in most developed countries to prevent the importation, in certain circumstances, of pharmaceutical products, but such instruments risk becoming insufficient where substantial volumes of heavily discounted pharmaceuticals are sold to the poorest developing country markets, and the economic interest in trade diversion into high priced markets therefore may increase significantly.
Tá ionstraimí reachtacha agus rialála ann i bhformhór na dtíortha forbartha chun allmhairiú táirgí cógaisíochta a chosc in imthosca áirithe, ach tá an baol ann go mbeidh ionstraimí den sórt sin neamhleor i gcás ina bhfuil méideanna móra earraí cógaisaíochta á ndíol ar phraghsanna a bhfuil mór-lascaine déanta orthu leis na margaí sna tíortha is boichte atá i mbéal forbartha agus d'fhéadfadh ardú suntasach a theacht ar an leas eacnamaíoch a bhaineann le sraonadh trádála isteach i margaí ina bhfuil phraghsanna arda dá bharr.